04-Bio-A8 · Undated paper
Nivaar worked solution (AI-drafted; not reviewed by a licensed engineer)
Paper format: National Exams — 04-Bio-A8 Biophysical Measurements. Three hours, open book, any non-communicating calculator. Seven questions of equal value (20 marks each); five constitute a complete paper and only the first five appearing in the answer book are marked. All seven are solved here, because this set is a study resource rather than an examination script. Every question is qualitative/descriptive — there is no numerical data to compute — so each answer follows flowing prose with instrumentation block diagrams where the question explicitly asks for one.
Reference texts (the books an open-book candidate should have on the desk for this subject):
Question text not reproduced: the examination questions are © Engineers and Geoscientists BC. Open the official past paper (linked at the top of this page) to read the question, then follow the worked solution below.
This question covers the single-electrode demand/inhibit (VVI) pacemaker in three sub-parts, including a sub-part (iii) on single-electrode whole-chamber capture.
The single-electrode demand/inhibit pacemaker — the VVI mode in the standard pacemaker code (Ventricle paced, Ventricle sensed, Inhibited response) — uses one lead placed in the right ventricle that both senses the patient's intrinsic ventricular depolarization (the R-wave) and delivers the pacing stimulus through the same electrode. It is "synchronous" in the sense that it synchronizes its behaviour to the patient's own rhythm: on every cycle the device first listens for an intrinsic R-wave; if one is detected within the programmed escape interval, the pacemaker inhibits (withholds) its own output and simply restarts its timing window from that beat. Only if no intrinsic beat occurs before the escape interval expires does the device fire a pacing pulse. The device therefore paces on demand — only when the heart fails to beat on its own — rather than pacing at a fixed rate regardless of the patient's underlying rhythm (the older, now obsolete, fixed-rate/asynchronous mode).
The sense amplifier is a high-gain, band-limited differential amplifier that picks up the intracardiac electrogram from the lead tip, filtered to pass the R-wave's characteristic frequency content (roughly 10–30 Hz) while rejecting the much larger, slower T-wave and any afterpotential left by a preceding pacing pulse. The R-wave detector / refractory-logic block compares the amplified signal to a programmable sensing threshold and declares an intrinsic beat only once that threshold is crossed outside a blanking/refractory window that follows each sensed or paced event, which prevents the device from re-triggering on the tail of the same beat or on a paced afterpotential. The timing and inhibit/demand logic is the state machine at the heart of the device: it runs an escape-interval timer (the reciprocal of the programmed base pacing rate) that is reset to zero every time a genuine intrinsic beat is sensed; if the timer reaches its limit with no sensed beat, it issues a pace command. The pulse generator produces a constant-current (or constant-voltage) stimulus of programmed amplitude and pulse width, energized from the device's lithium battery, sized to reliably capture the myocardium with a safety margin above the measured pacing threshold while conserving battery life. Finally, the output circuit and lead/electrode interface couples that pulse to the myocardium through the same lead used for sensing, via a blocking capacitor that prevents any net DC current (which would cause electrode corrosion and tissue damage) from flowing into the heart.
Materials. The circuitry and a lithium–iodine primary cell (about 2.8 V, chosen for its very low self-discharge and multi-year life) are sealed in a laser-welded titanium case, which is biocompatible, corrosion-resistant and in unipolar pacing also serves as the return (anode) electrode; hermetic ceramic-to-metal feedthroughs carry the signals into an epoxy or polyurethane connector header. The lead is a coiled, fatigue-resistant cobalt–nickel alloy (MP35N) conductor insulated with silicone rubber or polyurethane, ending in a platinum–iridium (often porous, steroid-eluting) tip electrode held against the trabeculae by passive tines or an active-fixation helix; the porous platinum surface gives a large electrochemical area, low polarization and a stable, low capture threshold.
The demand/inhibit design is the most widely used pacemaker mode because it is both the simplest implantable configuration (a single lead, a single chamber) and the safest: an asynchronous, fixed-rate pacemaker can deliver a pacing pulse during the vulnerable period of a spontaneous beat's T-wave (the "R-on-T" phenomenon), which can trigger ventricular fibrillation, whereas the demand/inhibit device avoids competitive pacing entirely because it never fires when the patient's own conduction is adequate. It is also economical to implant and program, imposes the lowest surgical and lead-related risk of any pacing configuration, and it is adequate wherever the patient needs rate support rather than atrioventricular synchrony — for example a slow ventricular rate in permanent atrial fibrillation (where AV synchrony is unattainable anyway) or back-up pacing for intermittent block, which is why VVI (and its atrial equivalent, AAI) remain the workhorse single-chamber modes despite the availability of more complex dual-chamber devices.
A single stimulating electrode is sufficient because cardiac muscle is an electrical syncytium: individual myocytes are joined at intercalated discs by low-resistance gap junctions, which electrically couple the interiors of adjacent cells and let depolarizing current flow directly from one cell to the next with almost no series resistance. A pacing stimulus therefore needs only to depolarize the small patch of myocardium immediately under the electrode tip past its excitation threshold; once that patch fires, the depolarization wavefront propagates cell-to-cell through the gap-junction network in every direction away from the stimulus site, exactly as the normal sinus impulse propagates outward from the SA node without a dedicated conduction fibre to every cell. Because the chamber (atrium or ventricle) is continuous, gap-junction–coupled tissue rather than a set of electrically isolated cells, this self-propagating wavefront reaches and activates the entire chamber from the single point of initiation, so no additional electrodes are needed to physically contact every region — the myocardium itself acts as the distribution network. The only requirement on the pacing stimulus is that its amplitude and pulse width exceed the local capture threshold (a strength–duration relationship) so that the initial patch of tissue is reliably excited; propagation beyond that point is intrinsic to the tissue, not something the pacemaker circuit has to provide. (Because a right-ventricular paced wavefront spreads mainly cell-to-cell through working myocardium rather than through the fast His–Purkinje system, ventricular activation is slower than normal and the paced QRS is wide — but the whole chamber is still captured.)
A patient with intermittent complete heart block receives a single right-ventricular VVI lead; at implant the surgeon measures a 0.5 V capture threshold at the electrode tip and programs the output to 2.5 V/0.4 ms for a 5× safety margin, and each paced beat appears on the surface ECG as a pacing spike followed by a wide (left-bundle-branch-block pattern) but fully captured QRS complex, because the gap-junction network has carried the depolarization to the whole ventricle from that one stimulus site, only more slowly than the His–Purkinje system would.
